More than 600 drugs for women diseases in development
- Statins Lower Blood Lipids: How Long is a Course?
- Warning: Smartwatch Blood Sugar Measurement Deemed Dangerous
- Mifepristone: A Safe and Effective Abortion Option Amidst Controversy
- Asbestos Detected in Buildings Damaged in Ukraine: Analyzed by Japanese Company
- New Ocrevus Subcutaneous Injection Therapy Shows Promising Results in Multiple Sclerosis Treatmen
- Dutch Man Infected with COVID-19 for 613 Days Dies: Accumulating Over 50 Virus Mutations
More than 600 drugs for women diseases in development
- Red Yeast Rice Scare Grips Japan: Over 114 Hospitalized and 5 Deaths
- Long COVID Brain Fog: Blood-Brain Barrier Damage and Persistent Inflammation
- FDA has mandated a top-level black box warning for all marketed CAR-T therapies
- Can people with high blood pressure eat peanuts?
- What is the difference between dopamine and dobutamine?
- How long can the patient live after heart stent surgery?
More than 600 drugs for women diseases in development
Breast cancer, the second leading cause of cancer death in women, saw a 42% drop in mortality from 1989 to 2019 .
In cervical cancer, which is almost always caused by human papillomavirus (HPV) , the widespread availability of the HPV vaccine has reduced the prevalence of HPV infection by 86% among adolescent girls and young adult women since the vaccine became available in the United States . 71% .
Now, endometriosis drugs are also approved for the market (Orilissa) , which can greatly relieve the pain conditions of patients with this type of disease.
While great strides have been made, women face unique health challenges throughout their lives.
Women are more likely than men to be diagnosed with certain diseases , such as autoimmune diseases, depression, osteoporosis, Alzheimer’s disease , etc.
Nearly 40 percent of women will be diagnosed with a chronic disease, compared with 30 percent of men .
Additionally, women can also be misdiagnosed due to gender bias in healthcare, which ultimately delays appropriate care and treatment. Minority patients in developed countries such as the United States may face additional challenges due to racial disparities in health care.
Reassuringly, PhRMA recently released a report showing that in response to these challenges, biopharmaceutical research companies are developing 625 drugs for diseases that disproportionately or only affect women.
These include:
- 200 cancer drugs that mainly affect women , including 119 for breast cancer, 66 for ovarian cancer , 4 for uterine cancer , and 22 for cervical cancer .
- 133 drugs for neurological disorders , including Alzheimer’s disease, migraine and multiple sclerosis.
- 87 drugs for autoimmune diseases that doubled their prevalence in women, including lupus, myasthenia gravis, scleroderma and Sjögren’s syndrome.
- 45 medications for mental health disorders , which also doubled in women, including anxiety, depression, postpartum depression and eating disorders.
- 43 medications for respiratory diseases that disproportionately affect women , including asthma and chronic obstructive pulmonary disease.
- 37 medications for arthritis and musculoskeletal disorders , including fibromyalgia, osteoporosis, and rheumatoid arthritis.
- 34 medicines for eye diseases , including dry eye.
- 33 medications for obstetric / gynecologic health problems , including endometriosis, menopausal symptoms, polycystic ovary syndrome, pregnancy complications, and uterine fibroids.
- 23 medications for infectious diseases affecting women , including candidiasis, chlamydia, genital herpes, and urinary tract infections.
- Drugs for 14 other conditions that disproportionately affect women , including chronic fatigue syndrome, interstitial cystitis, irritable bowel syndrome, and persistent urination.
Refer to PhRMA ‘s ” Medicines in Development for Women’s Health 2022 Drug List “.
More than 600 drugs for women diseases in development
(source:internet, reference only)
Disclaimer of medicaltrend.org
Important Note: The information provided is for informational purposes only and should not be considered as medical advice.
